Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cerus Corp (NASDAQ:CERS)

2.15
Delayed Data
As of Jul 21
 -0.06 / -2.71%
Today’s Change
1.93
Today|||52-Week Range
7.64
-50.57%
Year-to-Date
No recent news for Cerus Corp.

Today’s Trading

Previous close2.21
Today’s open2.24
Day’s range2.11 - 2.24
Volume862,424
Average volume (3 months)1,132,971
Market cap$225.4M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-1.64%
Earnings growth (this year)-3.63%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+14.76%
P/E ratioNM
Price/Sales11.28
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
UTMDUtah Medical Product...-1.10-1.52%
TIGTigenix NV+0.05+0.24%
OBLNObalon Therapeutics ...-0.10-1.12%
CVRSCorindus Vascular Ro...-0.03-1.78%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$39.3M
Annual profit (last year)-$62.9M
Net profit margin-160.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
William Mariner Greenman
Vice President-Manufacturing &
Operations
Suzanne Margerum
Corporate headquarters
Concord, California

Forecasts